Comparison of EBOV GP IgG Antibody Reactivity: Results from Two Immunoassays in the Democratic Republic of the Congo

By sjmartinez • April 8, 2025

Merritt S, Halbrook M, Kompany JP, Chandrasekaran P, Smith OA, Hoff NA, Tambu M, Martin SA, Wong TA, Jarra A, Barrall AL, Musene K, Beya M, Orr R, Myers T, MacGill T, Hensley LE, Muyembe-Tamfum JJ, Kaba D, Berry IM, Mbala-Kingebeni P, Lehrer AT, Rimoin AW. Comparison of EBOV GP IgG Antibody Reactivity: Results from Two Immunoassays in the Democratic Republic of the Congo. J Virol Methods. 2025 Apr 5:115154. doi: 10.1016/j.jviromet.2025.115154. Epub ahead of print. PMID: 40194662.

Tags: Democratic Republic of the Congo, EBOV GP, immunoassays, Infectious Diseases, Publications, serosurveillance

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Munroe ES, Grandits GA, Hyzy RC, Prescott HC, Barrett TW, Dewar RL, Engen N, Goodman AL, Hatlen TJ, Highbarger H, Holland TL, Hughes G, Jensen[...]

Three Cases of Vertical Transmission of Clade Ib Mpox Virus

Vakaniaki EH, Kuispond NS, Hirata Y, Bangwen E, Brosius I, Kinganda-Lusamaki E, Ozono S, Katano H, Ndunge LG, Mulopo-Mukanya N, Tshomba JC, De Vos E,[...]

Pearls and Pitfalls of Intrathecal Amphotericin B Therapy for Refractory Coccidioidal Meningitis in Children: An Illustrative Pediatric Case Series

Malhotra S, Adachi K, Fallah A, Johnson R, Ishminder Kaur, McCarty J, Ross L, Krogstad P. Pearls and Pitfalls of Intrathecal Amphotericin B Therapy for[...]